Nuvectis Pharma Inc. (NVCT) Live Share Price, Invest From India

Nuvectis Pharma Inc. Stock Performance

as on June 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$11.14
Day's Price Range
$12.08
$11.94
6.70%
Downside
1.17%
Upside
52 Week's Low
52 Week's High
$5.55
52-Week Price Range
$13.34
$11.94
53.52%
Downside
11.73%
Upside

Nuvectis Pharma Inc. share price movements today

Previous Close: $11.15
Open: $11.24
Volume: 291.9K
Day's Low - High: $11.14 - $12.08
52 Week Low - High: $5.55 - $13.34

Nuvectis Pharma Inc. Historical Returns

1 Month Return: + 8.15 %
3 Month Return: + 37.08 %
1 Year Return: + 47.23 %
3 Year Return: -34.03 %
5 Year Return: 0 %

Nuvectis Pharma Inc. Stock Fundamentals & Key Indicators

Check Nuvectis Pharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$304.5M

EPS (TTM)

-1.046

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-154.43%

Nuvectis Pharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nuvectis Pharma Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Nuvectis Pharma Inc.	BUY	$304.5M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.4B	63.66%	72.49	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.3B	140.59%	26.73	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.5B	14.69%	15.02	29.65%	0.58%

Stock Returns calculator for Nuvectis Pharma Inc. Stock including INR - Dollar returns

The Nuvectis Pharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Nuvectis Pharma Inc. investment value today

Current value as on today

₹1,61,182

Returns

₹61,182

(+61.18%)

Returns from Nuvectis Pharma Inc. Stock

₹47,226 (+47.23%)

Dollar Impact

₹13,956 (+13.96%)

Analyst Recommendation on Nuvectis Pharma Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Nuvectis Pharma Inc.. Average target price of $17.4

Nuvectis Pharma Inc. Share Price Target

Get share price movements and forecasts by analysts on Nuvectis Pharma Inc..

What analysts predicted

31.38%UPSIDE

Target Price

$17.4

Current Price

$11.94

Analyzed by

9 Analysts

Target

$17.40

Nuvectis Pharma Inc. target price $17.4, a slight upside of 31.38% compared to current price of $11.94. According to 9 analysts rating.

Indian Investors' Interest in Nuvectis Pharma Inc. Stock

Search interest for Nuvectis Pharma Inc. Stock has increased by 125% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 18, 2026 to June 17, 2026

Change:125% versus previous 30 day period

Nuvectis Pharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-4	-	-	-	26	-	-	-	-	-
Gross Profit	-15	-4	-4	-4	13	-	-	-	-	-
Operating Income	-6	-4	-4	-4	-6	-5	-6	-7	-7	-6
EBITDA	-6	-4	-4	-4	-6	-5	-6	-7	-8	-6
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-6	-4	-4	-4	-6	-5	-6	-7	-7	-6
Income Tax Expense	0	0	-	-	-	-	-	-	-	-
Net Income	-6	-4	-4	-4	-6	-5	-6	-7	-7	-6
Net Profit Margin	161.47%	0.00%	0.00%	0.00%	-23.32%	0.00%	0.00%	0.00%	0.00%	0.00%

Nuvectis Pharma Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	0	-	-	-
Gross Profit	-12	-19	-22	-	-
Operating Income	-12	-19	-22	-19	-27
EBITDA	-12	-18	-22	-19	-26
Interest Expense	0	0	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-12	-19	-22	-19	-26
Income Tax Expense	0	0	0	-19	-
Net Income	-12	-18	-22	-19	-26
Net Profit Margin	0.00%	-12608.72%	0.00%	0.00%	0.00%

Nuvectis Pharma Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-4	-4	-4	-6	-5	-6	-9	-7	-6
Operating Cash Flow	-4	-3	-2	-2	-4	-3	-4	-3	-6
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	4	1	1	3	15	0	13	0	0
Change in Cash	0	-1	0	1	11	-3	8	-3	-6

Nuvectis Pharma Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-12	-19	-22	-19	-26
Operating Cash Flow	-9	-13	-15	-12	-16
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	15	27	15	11	29
Change in Cash	5	14	0	0	13

Global Institutional Holdings in Nuvectis Pharma Inc.

Funds	Holdings
Vanguard Group Inc	3.19%
Nuveen, LLC	0.06%
Vanguard Capital Management, LLC	2.49%
Vanguard Fiduciary Trust Co	0.43%
Oppenheimer & Co Inc	0.28%

See all

Insights on Nuvectis Pharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NVCT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 7 days, NVCT stock has moved up by 15.8%
NO EFFECT
Against Peers
In the last 3 years, Nuvectis Pharma, Inc. Common Stock has experienced a drawdown of -34.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 12.5%

About Nuvectis Pharma Inc.

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Organisation	Nuvectis Pharma Inc.
Headquarters	1 Bridge Plaza, Fort Lee, NJ, United States, 07024
Industry	Biotechnology
CEO	Mr. Ron Bentsur M.B.A.
E-voting on shares	Click here to vote

Key Management of Nuvectis Pharma Inc.

Name	Title
Mr. Ron Bentsur M.B.A.	Co-Founder, Chairman, CEO & President
Dr. Enrique Poradosu Ph.D.	Co-Founder, Executive VP, Chief Scientific & Business Officer
Mr. Shay Shemesh	Co-Founder, Executive VP, Chief Development & Operations Officer
Mr. Michael Carson CPA	Vice President of Finance

FAQs

What is Nuvectis Pharma Inc. share price today?

Nuvectis Pharma Inc. share price today is $11.94 as on June 17, 2026 at 8:46 am IST at the close of the market. Nuvectis Pharma Inc. share today touched a day high of $12.08 and a low of $11.14.

What is the 52 week high and 52 week low for Nuvectis Pharma Inc. share?

Nuvectis Pharma Inc. share touched a 52 week high of $13.34 on May 14, 2026 and a 52 week low of $5.55 on November 7, 2025. Nuvectis Pharma Inc. stock price today i.e. June 17, 2026 at 8:46 am IST is closed at $11.94,which is 10.49% down from its 52 week high and 115.14% up from its 52 week low.

What is Nuvectis Pharma Inc.'s market capitalisation today?

Nuvectis Pharma Inc. market capitalisation is $0.00T as on June 17, 2026 at 8:46 am IST.

How to invest in Nuvectis Pharma Inc. Stock (NVCT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nuvectis Pharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nuvectis Pharma Inc. Shares that will get you 0.1256 shares as per Nuvectis Pharma Inc. share price of $11.94 per share as on June 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy Nuvectis Pharma Inc. Stock (NVCT) from India?

Indian investors can start investing in Nuvectis Pharma Inc. (NVCT) shares with as little as ₹94.5 or $1 (as of June 17, 2026 at 6:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Nuvectis Pharma Inc. stock (as per the Rupee-Dollar exchange rate as on June 17, 2026 at 6:42 pm IST). Based on Nuvectis Pharma Inc. share’s latest price of $11.94 as on June 17, 2026 at 8:46 am IST, you will get 0.8375 shares of Nuvectis Pharma Inc.. Learn more about fractional shares .